23.10.2018, 2122 Zeichen
AT&S: AT&S, a leading high tech PCB company, has increased the forecast for revenue and earnings. The very good business development is essentially attributable to higher revenue from the plants in Chongqing, which were in part still in the start-up phase in the previous year, as well as to measures to improve efficiency and productivity, the company stated. In addition, the superior product portfolio for IC substrates (for example server applications) contributes to the increase in earnings. As a result, AT&S now has the following expectations for the financial year 2018/19: based on stable exchange rates, the management expects revenue growth of 6 to 8% (previously up to 6%) and an EBITDA margin in the range of 24 to 26% (previously up to 23%) for the financial year 2018/19.
AT&S: weekly performance:
Do&Co: Austrian well known catering company Do&Co announced that it has agreed with Türk Havayolları A.O. to extend the cooperation through the joint company THY DO&CO İkram Hizmetleri A.Ş. for further 15 years subject to board and regulatory approvals and satisfactory documentation.
DO&CO: weekly performance:
Sanochemia: Sanochemia Pharmazeutika AG, an Austrian company that focuses on the development and manufacture of novel drugs and diagnostics in selected indication areas, announced that the United States Patent and Trademark Office has issued “Notice of Allowance“ for Vidon® in Photodynamic Therapy (PDT) of bladder cancer. Vidon® (PVP-Hypericin) is one of Sanochemia`s promising pipeline products and is being developed as a game changing technology in the management of bladder cancer. The patent covers the method for therapy of bladder cancer with Sanochemia’s developed PVP-Hypericin formulation. The U.S. patent will protect Vidon® until 2035. “The Notice of Allowance for the US application of Vidon® for PDT is an important milestone to secure the long-term value of Vidon® for Sanochemia”, said Christina Abrahamsberg, CSO of Sanochemia Pharmazeutika AG.
Sanochemia: weekly performance:
(From the 21st Austria weekly https://www.boerse-social.com/21staustria (23/10/2018)
SportWoche Podcast #123: Hans Huber und Christian Drastil über persönliche Highlights der starken Olympischen Spiele in Paris
Aktien auf dem Radar:Rosenbauer, SBO, Polytec Group, Austriacard Holdings AG, Addiko Bank, Strabag, Zumtobel, Porr, Bawag, Rosgix, Telekom Austria, AT&S, CA Immo, Erste Group, ams-Osram, BTV AG, Marinomed Biotech, Pierer Mobility, Oberbank AG Stamm, Agrana, Amag, EVN, Flughafen Wien, Immofinanz, Palfinger, Österreichische Post, RHI Magnesita, S Immo, Uniqa, VIG, Wienerberger.
Valneva
Valneva ist ein Impfstoffunternehmen, das sich auf die Entwicklung und Vermarktung von prophylaktischen Impfstoffen gegen Infektionskrankheiten mit hohem ungedeckten medizinischen Bedarf spezialisiert hat.
>> Besuchen Sie 68 weitere Partner auf boerse-social.com/partner
Die Useletter "Morning Xpresso" und "Evening Xtrakt" heben sich deutlich von den gängigen Newslettern ab.
Beispiele ansehen bzw. kostenfrei anmelden. Wichtige Börse-Infos garantiert.
Newsletter abonnieren
Infos über neue Financial Literacy Audio Files für die Runplugged App
(kostenfrei downloaden über http://runplugged.com/spreadit)
per Newsletter erhalten